Premium Pharmaceuticals Pvt Ltd - Charges

Every charge - open or closed - that lenders have registered against Premium Pharmaceuticals Pvt Ltd, with the most recent activity at the t…

1995-03-21 Ludhiana, Punjab Strike Off Unlisted Active Compliant
Share
Connect MCP
PP Premium Pharmaceuticals Pvt Ltd
Open charges
0
0.00
Closed charges
4
31.00 Lakh
Total
4
31.00 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Bank Of India 4 31.00 Lakh
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
90311686 Bank Of India 06 Feb 2002 - 17 Mar 2022 2.00 Lakh Closed
90174032 Bank Of India 06 Feb 2002 - 17 Mar 2022 20.00 Lakh Closed
90173403 Bank Of India 28 Feb 1997 15 Jan 2003 17 Mar 2022 2.00 Lakh Closed
90311012 Bank Of India 28 Feb 1997 14 Jul 2008 06 Jul 2020 7.00 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Premium Pharmaceuticals Pvt Ltd?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Premium Pharmaceuticals Pvt Ltd (CIN: U24232PB1995PTC016068). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Premium Pharmaceuticals Pvt Ltd.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.